Stock Research: GE Healthcare

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

GE Healthcare

NSQ:GEHC US36266G1076
56
  • Value
    7
  • Growth
    47
  • Safety
    Safety
    89
  • Combined
    47
  • Sentiment
    76
  • 360° View
    360° View
    56
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 56 (better than 56% compared with alternatives), overall professional sentiment and financial characteristics for the stock GE Healthcare are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for GE Healthcare. The consolidated Value Rank has an attractive rank of 89, which means that the share price of GE Healthcare is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 89% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 76, which means that professional investors are more optimistic about the stock than for 76% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 47, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 7, meaning the company has a riskier financing structure than 93 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
89 99 n/a n/a
Growth
47 27 n/a n/a
Safety
Safety
7 19 n/a n/a
Sentiment
76 94 n/a n/a
360° View
360° View
56 85 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
50 44 n/a n/a
Opinions Change
50 83 n/a n/a
Pro Holdings
n/a 90 n/a n/a
Market Pulse
79 87 n/a n/a
Sentiment
76 94 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
89 99 n/a n/a
Growth
47 27 n/a n/a
Safety Safety
7 19 n/a n/a
Combined
47 45 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
70 71 n/a n/a
Price vs. Earnings (P/E)
59 59 n/a n/a
Price vs. Book (P/B)
52 52 n/a n/a
Dividend Yield
80 90 n/a n/a
Value
89 99 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
25 21 n/a n/a
Profit Growth
31 41 n/a n/a
Capital Growth
83 33 n/a n/a
Stock Returns
47 59 n/a n/a
Growth
47 27 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
22 31 n/a n/a
Refinancing
11 4 n/a n/a
Liquidity
67 82 n/a n/a
Safety Safety
7 19 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to GE Healthcare and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.